We hypothesized that NRBP2 could be endowed with tumor-reducing capacity, and base this assumption on the findings presented in this study, and a publication on hepatocellular carcinoma [11] that suggested NRBP2 to increase sensitivity to chemotherapy. This evidence concerns the gene NRBP2 and neoplasm.